Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Exercise or conversion Director acquired 60,698 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Gift Director gave 7,201 shares (gift)
  10. 4 Open-market sale Director sold 30,000 shares at $7.85 ($235,500)
  11. 4 Exercise or conversion Director acquired 14,403 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 12,345 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 12,345 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Director sold 11,938 shares at $7.65 ($91,338)
  18. 4 Open-market sale Director sold 18,062 shares at an average $7.93 ($143,156)
  19. 4 Exercise or conversion President & CEO acquired 12,345 shares (option exercise)
  20. 4 Open-market buy CFO & COO bought 5,300 shares at an average $6.22 ($32,940)

Page 14 of 19 · 370 filings